Metformin may lower the risk for long COVID at 1 year after SARS-CoV-2 infection in people with overweight or obesity, according to a study published in Clinical Infectious Diseases. People with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback